Rating
Note: When evaluating any claim involving loss or loss of use of one or more creative organs, refer to §3.350 of this chapter to determine whether the veteran may be entitled to special monthly compensation. Footnotes in the schedule indicate conditions which potentially establish entitlement to special monthly compensation; however, there are other conditions in this section which under certain circumstances also establish entitlement to special monthly compensation.
7500   Kidney, removal of one:
Minimum evaluation 30
Or rate as renal dysfunction if there is nephritis, infection, or pathology of the other.
7501   Kidney, abscess of:
Rate as urinary tract infection
7502   Nephritis, chronic:
Rate as renal dysfunction.
7504   Pyelonephritis, chronic:
Rate as renal dysfunction or urinary tract infection, whichever is predominant.
7505   Kidney, tuberculosis of:
Rate in accordance with §§4.88b or 4.89, whichever is appropriate.
7507   Nephrosclerosis, arteriolar:
Rate according to predominant symptoms as renal dysfunction, hypertension or heart disease. If rated under the cardiovascular schedule, however, the percentage rating which would otherwise be assigned will be elevated to the next higher evaluation.
7508   Nephrolithiasis:
Rate as hydronephrosis, except for recurrent stone formation requiring one or more of the following:
1. diet therapy
2. drug therapy
3. invasive or non-invasive procedures more than two times/year 30
7509   Hydronephrosis:
Severe; Rate as renal dysfunction.
Frequent attacks of colic with infection (pyonephrosis), kidney function impaired 30
Frequent attacks of colic, requiring catheter drainage 20
Only an occasional attack of colic, not infected and not requiring catheter drainage 10
7510   Ureterolithiasis:
Rate as hydronephrosis, except for recurrent stone formation requiring one or more of the following:
1. diet therapy
2. drug therapy
3. invasive or non-invasive procedures more than two times/year 30
7511   Ureter, stricture of:
Rate as hydronephrosis, except for recurrent stone formation requiring one or more of the following:
1. diet therapy
2. drug therapy
3. invasive or non-invasive procedures more than two times/year 30
7512   Cystitis, chronic, includes interstitial and all etiologies, infectious and non-infectious:
Rate as voiding dysfunction.
7515   Bladder, calculus in, with symptoms interfering with function:
Rate as voiding dysfunction
7516   Bladder, fistula of:
Rate as voiding dysfunction or urinary tract infection, whichever is predominant.
Postoperative, suprapubic cystotomy 100
7517   Bladder, injury of:
Rate as voiding dysfunction.
7518   Urethra, stricture of:
Rate as voiding dysfunction.
7519   Urethra, fistual of:
Rate as voiding dysfunction.
Multiple urethroperineal fistulae 100
7520   Penis, removal of half or more 30
Or rate as voiding dysfunction.
7521   Penis removal of glans 20
Or rate as voiding dysfunction.
7522   Penis, deformity, with loss of erectile power-201
7523   Testis, atrophy complete:
Both-201
One-01
7524   Testis, removal:
Both-301
One-01
Note: In cases of the removal of one testis as the result of a service-incurred injury or disease, other than an undescended or congenitally undeveloped testis, with the absence or nonfunctioning of the other testis unrelated to service, an evaluation of 30 percent will be assigned for the service-connected testicular loss. Testis, underscended, or congenitally undeveloped is not a ratable disability.
7525   Epididymo-orchitis, chronic only:
Rate as urinary tract infection.
For tubercular infections: Rate in accordance with §§4.88b or 4.89, whichever is appropriate.
7527   Prostate gland injuries, infections, hypertrophy, postoperative residuals:
Rate as voiding dysfunction or urinary tract infection, whichever is predominant.
7528   Malignant neoplasms of the genitourinary system 100
Note-Following the cessation of surgical, X-ray, antineoplastic chemotherapy or other therapeutic procedure, the rating of 100 percent shall continue with a mandatory VA examination at the expiration of six months. Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of §3.105(e) of this chapter. If there has been no local reoccurrence or metastasis, rate on residuals as voiding dysfunction or renal dysfunction, whichever is predominant.
7529   Benign neoplasms of the genitourinary system:
Rate as voiding dysfunction or renal dysfunction, whichever is predominant.
7530   Chronic renal disease requiring regular dialysis:
Rate as renal dysfunction.
7531   Kidney transplant:
Following transplant surgery 100
Thereafter: Rate on residuals as renal dysfunction, minimum rating 30
Note-The 100 percent evaluation shall be assigned as of the date of hospital admission for transplant surgery and shall continue with a mandatory VA examination one year following hospital discharge. Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of §3.105(e) of this chapter.
7532   Renal tubular disorders (such as renal glycosurias, aminoacidurias, renal tubular acidosis, Fanconi’s syndrome, Bartter’s syndrome, related disorders of Henle’s loop and proximal or distal nephron function, etc.):
Minimum rating for symptomatic condition 20
Or rate as renal dysfunction.
7533   Cystic diseases of the kidneys (polycystic disease, uremic medullary cystic disease, Medullary sponge kidney, and similar conditions):
Rate as renal dysfunction.
7534   Atherosclerotic renal disease (renal artery stenosis or atheroembolic renal disease):
Rate as renal dysfunction.
7535   Toxic nephropathy (antibotics, radiocontrast agents, nonsteroidal anti-inflammatory agents, heavy metals, and similar agents):
Rate as renal dysfunction.
7536   Glomerulonephritis:
Rate as renal dysfunction.
7537   Interstitial nephritis:
Rate as renal dysfunction.
7538   Papillary necrosis:
Rate as renal dysfunction.
7539   Renal amyloid disease:
Rate as renal dysfunction.
7540   Disseminated intravascular coagulation with renal cortical necrosis:
Rate as renal dysfunction.
7541   Renal involvement in diabetes mellitus, sickle cell anemia, systemic lupus erythematosus, vasculitis, or other systemic disease processes.
Rate as renal dysfunction.
7542   Neurogenic bladder:
Rate as voiding dysfunction.

1Review for entitlement to special monthly compensation under §3.350 of this chapter.

[59 FR 2527, Jan. 18, 1994; 59 FR 14567, Mar. 29, 1994, as amended at 59 FR 46339, Sept. 8, 1994]